Why UiPath is on investors’ radar right now UiPath (PATH) has drawn fresh attention after recent share price moves, with the stock showing mixed short term performance and a deeper pullback over the ...

This agentic AI provider offers excellent prospects at a reasonable price.

If you are wondering whether UiPath's current share price actually lines up with its underlying business, you are not alone. This article is designed to help you make sense of what you are paying for.

Specializing in automation software for enterprises, this tech firm reported a notable insider sale amid ongoing shifts in ...

UiPath’s latest valuation work keeps the fair value marker steady at about US$16.40, even as the discount rate and revenue growth assumptions are nudged only slightly. Those small tweaks reflect how ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

UiPath has been bruised badly in recent years, but the latest quarter offers hope. As demand for agents and automation picks up, perhaps the Street-high price target of $17 is due for a hike. Follow ...

UiPath is well-positioned in the fast-growing agentic AI market, with its enhanced cross-vendor orchestration capabilities.

The average one-year price target for UiPath (NYSE:PATH) has been revised to $15.99 / share. This is an increase of 15.84% from the prior estimate of $13.80 dated November 14, 2025. The price target ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

UiPath (NYSE:PATH) reported its first quarter of operating profit, signaling progress in its move toward more disciplined operations. Around the same time, CEO Daniel Dines sold shares under a ...

UiPath has flown under the media's radar despite some heavy Wall Street investment late last year, is it worth a look?